IGF-1 LR3

IGF-1 LR3 Canada: Research Product

IGF-1 LR3 Canada researchers can order Long R3 IGF-1 directly from Red Leaf Research Labs. This listing supplies lyophilized IGF-1 LR3 for qualified laboratory use, with published analytical information, Canadian-dollar pricing and domestic express fulfilment.

For searches such as buy IGF-1 LR3 Canada, Long R3 IGF-1 Canada or IGF-1 LR3 research peptide, the practical questions are the same ones that apply to any research protein: what is in the vial, who tested it, when it was tested, and whether the buyer is authorized to obtain research-use material.

Red Leaf Research Labs supplies research material to qualified purchasers in Canada. Nothing on this page describes a therapy, a treatment or a permitted personal use.

IGF-1 LR3 Research Format and Options

IGF-1 LR3 Research Specifications

• Compound name: IGF-1 LR3
• Full name: Long R3 insulin-like growth factor 1
• Class: Recombinant analogue of human IGF-1
• Length: 83 amino acids — the 70-residue IGF-1 sequence plus a 13-residue N-terminal extension
• Key modification: Arginine substituted for glutamic acid at position 3, which is what the “R3” denotes
• CAS number: 946870-92-4
• Molecular formula: C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₉
• Approximate molecular weight: 9.1 kDa
• Research interest: Reduced affinity for IGF-binding proteins relative to native IGF-1
• Physical format: Lyophilized powder
• Intended use: Qualified laboratory research only
• Fulfilment: Domestic Canadian express shipping

What Is IGF-1 LR3?

IGF-1 LR3 is an engineered version of insulin-like growth factor 1 carrying two deliberate changes: a thirteen-amino-acid extension on the N-terminus, and an arginine in place of glutamic acid at position three.

Both changes exist for the same reason. Native IGF-1 circulates bound to a family of IGF-binding proteins that regulate its availability, and in a cell-culture system those binding proteins complicate interpretation of results. The LR3 modifications substantially reduce binding-protein affinity, which is why the analogue became a standard reagent in mammalian cell culture — it delivers a more consistent growth signal in a defined medium than native IGF-1 does.

That origin is worth stating plainly: IGF-1 LR3 was developed as a cell-culture reagent, and the bulk of its documented use is in bioprocessing and laboratory culture systems rather than in whole-organism work.

Why the Binding-Protein Difference Matters in a Research Setting

A laboratory choosing between native IGF-1 and IGF-1 LR3 is choosing between two different experimental behaviours, not two grades of the same thing. Native IGF-1 in a serum-containing system is partly sequestered by binding proteins present in the serum; LR3 largely is not. That makes LR3 more potent in culture at equivalent concentration and, more importantly, more reproducible between runs.

It also makes results from the two non-interchangeable. A protocol validated with one should not be assumed to transfer to the other, and published findings should be read with attention to which molecule was actually used.

Why Buy IGF-1 LR3 in Canada from a Domestic Research Supplier?

Recombinant proteins in the 9 kDa range are more sensitive to their journey than the short peptides that surround them on a catalogue. Agitation during transit promotes aggregation, and temperature cycling compounds it — both are failure modes that a pre-shipment certificate cannot anticipate.

Shorter domestic transit reduces that exposure, and a Canadian counterparty gives you somewhere to go when a lot does not match its paperwork. Neither substitutes for checking the material on arrival.

How This IGF-1 LR3 Canada Page Improves on Typical Competitor Listings

• The modification is explained. Most listings print “LR3” without saying what the letters mean or why the molecule was engineered.
• Its actual research context is stated. IGF-1 LR3 is a cell-culture reagent by origin, and this page says so.
• Native IGF-1 is distinguished. The two are not interchangeable, and documentation for one does not describe the other.
• Stated analytical basis. Purity is presented as a measured result tied to a lot and a method.
• No outcome claims. This listing does not describe experiences, results or benefits.

How to Evaluate an IGF-1 LR3 Certificate of Analysis

For a 9 kDa recombinant protein the report needs to establish more than composition. Aggregation and truncation are the realistic failure modes.

1. Named molecule: IGF-1 LR3 — not native IGF-1, and not “IGF-1 analogue”.
2. Mass confirmation: approximately 9.1 kDa. Native IGF-1 comes in near 7.6 kDa, so the two separate cleanly.
3. Aggregation: whether high-molecular-weight species were looked for. This is the check most reports omit and most laboratories need.
4. Truncation: whether lower-mass fragments were detected.
5. Lot reference and date: cross-check both against the vial.
6. Reported quantity: should reconcile with the format supplied.
7. Independent check: a verification reference you can put to the issuing laboratory.

Red Leaf publishes Janoshik reports with a verification key. For recombinant proteins, a purity figure with no integrity data behind it tells you what the material is made of but not whether it still works.

IGF-1 LR3 Lyophilized Research Format

The vial arrives as a lyophilized cake. Lyophilization stabilises the protein for transport; it does not confer indefinite stability and it does not undo damage already done.

The specific risk with a 9 kDa recombinant protein is aggregation, and it is largely driven by handling rather than by storage: vortexing, foaming and repeated freeze-thaw all promote it. Reconstitute gently, aliquot at first preparation rather than returning to one vial repeatedly, and avoid vigorous mixing. Inspect the cake, connect the vial to its report, and follow validated institutional procedures. Background on diluent choice is in bacteriostatic water uses and handling.

How to Buy IGF-1 LR3 in Canada for Qualified Research

1. Establish eligibility. Confirm the purchaser and institution are authorized to hold research-use material.
2. Confirm it is the LR3 analogue on the report, not native IGF-1 — the two behave differently in serum-containing systems.
3. Decide your aliquoting strategy before reconstitution. Repeated freeze-thaw is the main avoidable cause of loss with this protein.
4. Arrange cold storage in advance.
5. Log it in. Lot reference, arrival condition, storage location, against the study plan.

Fulfilment is to qualified Canadian purchasers by domestic express. Red Leaf supplies material and documentation; it does not advise on study design and provides nothing that supports use in humans or animals.

IGF-1 LR3 Availability in Canada: Research vs. Consumer Searches

IGF-1 LR3 holds no marketing authorization in Canada as a consumer or clinical product. It is a laboratory reagent, supplied and documented as one.

Research supply and public medical availability are separate categories. A vial available to a qualified laboratory is not an approved retail medicine, a pharmacy product, or a substitute for professional care. Anyone searching from a personal health motivation should speak with a licensed clinician rather than a research supplier.

IGF-1 LR3 Canada Procurement Checklist

Explore IGF-1 LR3 Research Information

For supplier-selection criteria in the Canadian market, review how to evaluate a Canadian research peptide supplier. For a wider survey of compounds studied in growth and repair signalling, see peptides studied in muscle-growth research.

IGF-1 LR3 research FAQ

What does “LR3” mean?

“L” refers to the thirteen-amino-acid N-terminal extension that lengthens the molecule; “R3” refers to the arginine substituted for glutamic acid at position 3. Together they reduce affinity for IGF-binding proteins.

Is IGF-1 LR3 the same as IGF-1?

No. It is an engineered analogue with different binding-protein behaviour. Protocols and documentation for one do not transfer to the other.

Why was it developed?

As a cell-culture reagent. Reduced binding-protein interference gives a more consistent and reproducible growth signal in defined media than native IGF-1.

What should Canadian laboratories verify before ordering?

Confirm intended use, lot identity, analytical documentation, cold-chain requirements and institutional approval before purchase.

Does Red Leaf Research Labs provide dosing information?

No. Red Leaf Research Labs supplies research material and analytical documentation only.

Research use only. IGF-1 LR3 supplied by Red Leaf Research Labs is intended for qualified laboratory research. It is not a medicine, not for human or veterinary use, and not for diagnostic or therapeutic application.